Nautilus Biotechnology, Inc. Long-term Purchase Commitment, Amount
Nautilus Biotechnology, Inc. (NAUT) reported Long-term Purchase Commitment, Amount of $3.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2026-07-28
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for the quarter ending 2026-06-30 was $900.00K.
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for the quarter ending 2026-03-31 was $2.30M, a 9.52% increase year-over-year.
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for the quarter ending 2025-12-31 was $300.00K.
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for the quarter ending 2025-09-30 was -$300.00K, a 250.00% decline year-over-year.
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for fiscal 2025 was $1.50M, a 11.76% decline from fiscal 2024.
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for fiscal 2024 was $1.70M, a 32.00% decline from fiscal 2023.
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for fiscal 2023 was $2.50M, a 47.06% increase from fiscal 2022.
- Nautilus Biotechnology, Inc. long-term purchase commitment, amount for fiscal 2022 was $1.70M, a 43.33% decline from fiscal 2021.
| Period end | Long-term Purchase Commitment, Amount 3 month | Long-term Purchase Commitment, Amount 6 month | Long-term Purchase Commitment, Amount 9 month | Long-term Purchase Commitment, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $3.20M 10-Q · filed 2026-07-28 | $3.50M derived: sum of 3 quarters · filed 2026-07-28 | $3.20M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $2.30M 10-Q · filed 2026-04-28 | $2.60M derived: sum of 2 quarters · filed 2026-04-28 | $2.30M derived: sum of 3 quarters · filed 2026-04-28 | $1.70M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$600.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$900.00K derived: sum of 2 quarters · filed 2025-10-28 | $1.20M 10-Q · filed 2025-10-28 | $400.00K derived: sum of 4 quarters · filed 2025-10-28 |
| 2025-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $1.50M 10-Q · filed 2025-07-31 | $700.00K derived: sum of 3 quarters · filed 2025-07-31 | $900.00K derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | $2.10M 10-Q · filed 2025-04-29 | $1.30M derived: sum of 2 quarters · filed 2025-04-29 | $1.50M derived: sum of 3 quarters · filed 2025-04-29 | $1.40M derived: sum of 4 quarters · filed 2025-04-29 |
| 2024-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$600.00K derived: sum of 2 quarters · filed 2025-02-27 | -$700.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.70M 10-K · filed 2025-02-27 |
| 2024-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $100.00K derived: sum of 2 quarters · filed 2024-10-29 | $2.50M 10-Q · filed 2024-10-29 | $3.60M derived: sum of 4 quarters · filed 2024-10-29 |
| 2024-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $2.30M 10-Q · filed 2024-07-30 | $3.40M derived: sum of 3 quarters · filed 2024-07-30 | $3.50M derived: sum of 4 quarters · filed 2024-07-30 |
| 2024-03-31 | $2.40M 10-Q · filed 2024-04-30 | $3.50M derived: sum of 2 quarters · filed 2024-04-30 | $3.60M derived: sum of 3 quarters · filed 2024-04-30 | $3.50M derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.20M derived: sum of 2 quarters · filed 2024-02-28 | $1.10M derived: sum of 3 quarters · filed 2024-02-28 | $2.50M 10-K · filed 2024-02-28 |
| 2023-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $0.00 derived: sum of 2 quarters · filed 2023-10-31 | $1.40M 10-Q · filed 2023-10-31 | $1.40M derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.30M 10-Q · filed 2023-08-02 | $1.30M derived: sum of 3 quarters · filed 2023-08-02 | $1.00M derived: sum of 4 quarters · filed 2023-08-02 |
| 2023-03-31 | $1.40M 10-Q · filed 2023-05-02 | $1.40M derived: sum of 2 quarters · filed 2023-05-02 | $1.10M derived: sum of 3 quarters · filed 2023-05-02 | $500.00K derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$300.00K derived: sum of 2 quarters · filed 2023-02-23 | -$900.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.70M 10-K · filed 2023-02-23 |
| 2022-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$900.00K derived: sum of 2 quarters · filed 2022-11-01 | $1.70M 10-Q · filed 2022-11-01 | $1.80M derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.00M 10-Q · filed 2022-08-02 | $2.10M derived: sum of 3 quarters · filed 2022-08-02 | $3.60M derived: sum of 4 quarters · filed 2022-08-02 |
| 2022-03-31 | $2.60M 10-Q · filed 2022-05-03 | $2.70M derived: sum of 2 quarters · filed 2022-05-03 | $4.20M derived: sum of 3 quarters · filed 2022-05-03 | |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.60M derived: sum of 2 quarters · filed 2022-02-24 | $3.00M 10-K · filed 2022-02-24 | |
| 2021-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $2.90M 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | $1.40M 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |